Adiwijaya, Bambang,Fitzgerald, Jonathan Basil,Lee, Helen
申请号：
AU2017267449
公开号：
AU2017267449A1
申请日:
2017.05.17
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
Novel therapies for the treatment of small cell lung cancer (SCLC) include the administration of an antineoplastic therapy consisting of liposomal irinotecan administered once every two weeks, optionally including the administration of other non-antineoplastic agents to the patient such as the administration of a corticosteroid and an anti-emetic to the patient prior to the administration of the irinotecan liposome.
